NanoViricides, Inc. (NNVC)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
NNVC Insider Trading Activity
NNVC Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About NanoViricides, Inc.
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum …
Insider Activity of NanoViricides, Inc.
Over the last 12 months, insiders at NanoViricides, Inc. have bought $0 and sold $0 worth of NanoViricides, Inc. stock.
On average, over the past 5 years, insiders at NanoViricides, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $30,000 was made by BONIUK MILTON (director) on 2015‑11‑11.
List of Insider Buy and Sell Transactions, NanoViricides, Inc.
| 2015-11-11 | BONIUK MILTON | director | 25,000 0.0431% | $1.20 | $30,000 | +33.88% | ||
| 2015-10-22 | BONIUK MILTON | director | 14,640 0.0254% | $1.30 | $19,032 | +24.62% | ||
| 2015-10-21 | BONIUK MILTON | director | 5,202 0.009% | $1.30 | $6,763 | +24.62% | ||
| 2015-10-19 | BONIUK MILTON | director | 2,958 0.0051% | $1.30 | $3,845 | +22.73% | ||
| 2015-10-15 | BONIUK MILTON | director | 2,200 0.0037% | $1.30 | $2,860 | +20.00% | ||
| 2015-09-11 | BONIUK MILTON | director | 50,000 0.0873% | $1.02 | $51,000 | +53.92% | ||
| 2015-08-26 | BONIUK MILTON | director | 50,000 0.0921% | $1.05 | $52,500 | +55.65% | ||
| 2015-08-21 | BONIUK MILTON | director | 29,853 0.053% | $1.25 | $37,316 | +26.02% | ||
| 2015-08-20 | BONIUK MILTON | director | 2,662 0.0046% | $1.25 | $3,328 | +24.00% | ||
| 2015-08-19 | BONIUK MILTON | director | 300 0.0005% | $1.25 | $375 | +20.16% | ||
| 2015-08-18 | BONIUK MILTON | director | 2,547 0.0043% | $1.25 | $3,184 | +20.16% | ||
| 2015-08-17 | BONIUK MILTON | director | 5,244 0.0092% | $1.25 | $6,555 | +24.00% | ||
| 2015-08-14 | BONIUK MILTON | director | 8,594 0.0148% | $1.25 | $10,743 | +20.47% | ||
| 2015-08-13 | BONIUK MILTON | director | 800 0.0013% | $1.25 | $1,000 | +14.18% | ||
| 2015-07-08 | BONIUK MILTON | director | 50,000 0.092% | $1.58 | $79,000 | -6.00% | ||
| 2015-06-22 | BONIUK MILTON | director | 43,472 0.074% | $1.90 | $82,597 | -27.69% | ||
| 2015-06-19 | BONIUK MILTON | director | 6,528 0.0113% | $1.90 | $12,403 | -27.08% | ||
| 2015-06-16 | BONIUK MILTON | director | 42,247 0.0738% | $1.99 | $84,072 | -29.15% | ||
| 2015-06-15 | BONIUK MILTON | director | 7,753 0.0135% | $2.00 | $15,506 | -29.50% | ||
| 2015-05-20 | BONIUK MILTON | director | 25,000 0.0431% | $1.60 | $40,000 | -12.96% |
Insider Historical Profitability
| Seymour Eugene | Chief Executive Officer | 6025000 38.5206% | $7.29M | 1 | 0 | +75.74% |
| Diwan Anil | President | 2074918 13.2659% | $2.51M | 9 | 75 | +24.68% |
| BONIUK MILTON | director | 150000 0.959% | $181,500.00 | 35 | 0 | <0.0001% |
| VYAS MEETA | Chief Financial Officer | 147021 0.94% | $177,895.41 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$992,222,850 | 90 | -12.52% | $19.11M | |
NanoViricides, Inc. (NNVC) | $6,204,522 | 45 | 1.91% | $18.93M |
$550,024 | 37 | -2.68% | $19.79M | |
$85,897,100 | 36 | 2.47% | $16.75M | |
$217,684 | 34 | 1.61% | $17.84M |
NNVC Institutional Investors: Active Positions
| Increased Positions | 12 | +34.29% | 151,735 | +11.32% |
| Decreased Positions | 8 | -22.86% | 34,458 | -2.57% |
| New Positions | 7 | New | 82,731 | New |
| Sold Out Positions | 3 | Sold Out | 12,472 | Sold Out |
| Total Postitions | 39 | +11.43% | 1M | +8.75% |
NNVC Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $674.00 | 3.19% | 510,416 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $210.00 | 0.99% | 158,752 | 0 | 0% | 2024-12-31 |
| Compagnie Lombard Odier Scma | $198.00 | 0.94% | 150,000 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $192.00 | 0.91% | 145,700 | +30,800 | +26.81% | 2024-12-31 |
| Geode Capital Management, Llc | $189.00 | 0.9% | 143,313 | +31,956 | +28.7% | 2024-12-31 |
| Virtu Financial Llc | $84.00 | 0.4% | 63,644 | +63,644 | New | 2024-12-31 |
| Bridgeway Capital Management, Llc | $58.00 | 0.28% | 44,039 | 0 | 0% | 2024-12-31 |
| State Street Corp | $55.00 | 0.26% | 41,906 | 0 | 0% | 2024-12-31 |
| Integrated Wealth Concepts Llc | $50.00 | 0.24% | 38,035 | -15,300 | -28.69% | 2024-12-31 |
| Royal Bank Of Canada | $40.00 | 0.19% | 30,535 | 0 | 0% | 2024-12-31 |